Loading video...

Video Failed to Load

Go Home

We are about to publish the LARGEST human ivermectin-cancer study ever conducted. After 6 months, many patients reported their cancer was GONE. HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types.

NicHulscher's profile picture

Nicolas Hulscher, MPH

271,891 subscribers

1,691,840 views • 4 months ago •via X (Twitter)

Health & WellnessScience & Technology
LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith
1:30

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith

Nicolas Hulscher, MPH

19,219 views • 4 months ago

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.
1:44

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

1,052,068 views • 3 months ago

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.
0:37

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

5,203,743 views • 4 months ago

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.
0:43

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.

Joe Tippens

15,391 views • 1 month ago

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.
0:43

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.

Nicolas Hulscher, MPH

138,449 views • 1 month ago

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.
1:15

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,205 views • 6 months ago

Ivermectin exerts more than 12 distinct anticancer mechanisms on more than 12 types of cancer, according to hundreds of studies. The NIH has officially recognized it and has launched studies on ivermectin's ability to eliminate cancer cells.
1:01

Ivermectin exerts more than 12 distinct anticancer mechanisms on more than 12 types of cancer, according to hundreds of studies. The NIH has officially recognized it and has launched studies on ivermectin's ability to eliminate cancer cells.

Whiplash347

26,006 views • 4 months ago

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH
0:37

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

Valerie Anne Smith

30,754 views • 3 months ago

Ivermectin exerts over TWELVE distinct anti-cancer mechanisms across more than TWELVE cancer types — according to HUNDREDS of studies. And finally, the NIH has officially acknowledged this and launched studies on ivermectin’s ability to eliminate cancer cells.
1:01

Ivermectin exerts over TWELVE distinct anti-cancer mechanisms across more than TWELVE cancer types — according to HUNDREDS of studies. And finally, the NIH has officially acknowledged this and launched studies on ivermectin’s ability to eliminate cancer cells.

Nicolas Hulscher, MPH

245,288 views • 5 months ago

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.
1:20

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.

Nicolas Hulscher, MPH

22,556 views • 5 months ago

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 6 months, 84.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY.

Nicolas Hulscher, MPH

100,530 views • 4 months ago

We found 84% of cancer patients taking ivermectin and mebendazole declared their cancer was either COMPLETELY GONE, SHRUNK, or STOPPED SPREADING after 6 months. This explains why the CIA CLASSIFIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer.
1:15

We found 84% of cancer patients taking ivermectin and mebendazole declared their cancer was either COMPLETELY GONE, SHRUNK, or STOPPED SPREADING after 6 months. This explains why the CIA CLASSIFIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer.

Nicolas Hulscher, MPH

75,566 views • 3 months ago

We found 84% of cancer patients taking ivermectin and mebendazole for 6 months declared their cancer was either COMPLETELY GONE, REGRESSED, or STOPPED SPREADING. It’s no surprise the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.
0:58

We found 84% of cancer patients taking ivermectin and mebendazole for 6 months declared their cancer was either COMPLETELY GONE, REGRESSED, or STOPPED SPREADING. It’s no surprise the CIA BURIED a 1950s study for over HALF A CENTURY showing anti-parasitics disrupt cancer growth.

Nicolas Hulscher, MPH

2,384,907 views • 3 months ago

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️
0:37

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️

Catturd ™

252,551 views • 2 months ago

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).
1:12

Cancer reportedly DISAPPEARED or REGRESSED in nearly HALF of patients using ivermectin + mebendazole in the LARGEST real-world study to date. After just 4 months, 95.4% of cancer patients reported CLINICAL BENEFIT with these anti-parasitics. Clinical trials are now NECESSARY. Follow Dr. Zakaria MD. (Dr. Zakaria MD ).

Joe Tippens

30,145 views • 4 months ago

Mel Gibson wasn't lying to Joe Rogan... and the largest human ivermectin cancer study to date just confirmed it. We found 84.4% of cancer patients taking ivermectin for 6 months declared their cancer: DISAPPEARED (32.8%) SHRUNK (15.6%) STOPPED SPREADING (36.1%)
0:48

Mel Gibson wasn't lying to Joe Rogan... and the largest human ivermectin cancer study to date just confirmed it. We found 84.4% of cancer patients taking ivermectin for 6 months declared their cancer: DISAPPEARED (32.8%) SHRUNK (15.6%) STOPPED SPREADING (36.1%)

Nicolas Hulscher, MPH

124,685 views • 1 month ago

84.4% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH The LARGEST human ivermectin cancer study EVER conducted is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. We are WINNING.
0:58

84.4% of cancer patients taking ivermectin declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH The LARGEST human ivermectin cancer study EVER conducted is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. We are WINNING.

Nicolas Hulscher, MPH

181,149 views • 1 month ago

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.
1:15

Nearly HALF of cancer patients declared COMPLETE REMISSION or TUMOR SHRINKAGE in the largest human ivermectin cancer study ever conducted. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.

Nicolas Hulscher, MPH

53,132 views • 1 month ago

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.
1:34

🚨NEARLY HALF OF CANCER PATIENTS TAKING IVERMECTIN + MEBENDAZOLE REPORTED CANCER DISAPPEARANCE OR TUMOR REGRESSION AFTER 6 MONTHS 84.4% EXPERIENCED CLINICAL BENEFIT 32.8% REPORTED NO EVIDENCE OF DISEASE 15.6% REPORTED TUMOR REGRESSION 36.1% REPORTED STABLE DISEASE Our study represents the largest and most compelling clinical signal to date supporting antiparasitic therapy in cancer.

Joe Tippens

56,068 views • 4 months ago

The LARGEST human ivermectin cancer study EVER conducted found 84% of cancer patients declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. The tide is turning.
0:51

The LARGEST human ivermectin cancer study EVER conducted found 84% of cancer patients declared COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH. Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research. The tide is turning.

Nicolas Hulscher, MPH

1,958,117 views • 2 months ago